Status:
COMPLETED
Impact of Acute Normovolemic Hemodilution on Blood Viscosity
Lead Sponsor:
Konkuk University Medical Center
Conditions:
Ischemic Heart Disease
Coronary Artery Disease
Eligibility:
All Genders
Phase:
NA
Brief Summary
Acute normovolemic hemodilution (ANH) has long been employed for reducing allogenic blood transfusion for cardiac surgery, and hydroxyethyl starch has been used as an intravenous replacement fluid dur...
Eligibility Criteria
Inclusion
- patients undergoing off-pump coronary artery bypass graft surgery
Exclusion
- Preoperative anemia
- LV ejection fraction \< 50%
Key Trial Info
Start Date :
May 2 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 30 2018
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT03366753
Start Date
May 2 2018
End Date
November 30 2018
Last Update
December 29 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Konkuk University Medical Center
Seoul, South Korea, 143-729